Abstract
Data on the incidence of adverse liver outcomes are limited for cancer patients with chronic (hepatitis B surface antigen [HBsAg]-positive/hepatitis B core antibody [anti-HBc]-positive) or past (HBsAg-negative/anti-HBc-positive) hepatitis B virus (HBV) after chemotherapy. This study was aimed at determining the impact of test timing and anti-HBV therapy on adverse liver outcomes in these patients. Patients with solid or hematologic malignancies who received chemotherapy between 2004 and 2011 were retrospectively studied. HBV testing and anti-HBV therapy were defined as early at the initiation of cancer therapy and as late after initiation. Outcomes included hepatitis flares, hepatic impairment, liver failure, and death. Time-to-event analysis was used to determine incidence, and multivariate hazard models were used to determine predictors of outcomes. There were 18,688 study patients (80.4% with solid tumors). The prevalence of chronic HBV was 1.1% (52 of 4905), and the prevalence of past HBV was 7.1% (350 of 4905). Among patients with solid tumors, late identification of chronic HBV was associated with a higher risk of hepatitis flare (hazard ratio [HR], 4.02; 95% confidence interval [CI], 1.26-12.86), hepatic impairment (HR, ...Continue Reading
References
Jan 1, 1991·Gastroenterology·A S LokD Todd
Jan 16, 2004·Gastroenterology·George K K LauRaymond Liang
Apr 2, 2008·Annals of Internal Medicine·Rohit LoombaGyorgy Csako
Nov 28, 2012·Journal of Oncology Practice·Jessica P HwangMaria E Suarez-Almazor
May 9, 2013·British Journal of Cancer·W H Y LingS-C Lee
Nov 12, 2013·BMC Cancer·Jessica P HwangMaria E Suarez-Almazor
Nov 20, 2013·Nature Reviews. Gastroenterology & Hepatology·Jessica P Hwang, Anna S-F Lok
Dec 3, 2014·Gastroenterology·K Rajender ReddyUNKNOWN American Gastroenterological Association Institute
May 13, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jessica P HwangAndrew S Artz
Jun 5, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ping-I HsuHsien-Chung Yu
Nov 26, 2015·Annals of Internal Medicine·Sonali PaulJohn B Wong
Dec 20, 2015·Gastroenterology·Jang-June ParkUNKNOWN HBRN
Jan 29, 2016·Journal of Pharmaceutical Health Care and Sciences·Akimasa SanagawaKazunori Kimura
Jul 14, 2016·Journal of the National Comprehensive Cancer Network : JNCCN·Lindsey Robert BadenCourtney Smith
Citations
Mar 21, 2018·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Denise YeoAlexandre Chan
Feb 16, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jessica P HwangMaria E Suarez-Almazor
Jan 31, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas S Uldrick
Sep 25, 2017·The British Journal of Dermatology·R J de Knegt
Oct 10, 2018·Current Opinion in Infectious Diseases·Jessica P Hwang, Harrys A Torres
Mar 21, 2019·JCO Clinical Cancer Informatics·Jessica P HwangScott B Cantor
Apr 12, 2019·Journal of Viral Hepatitis·Romina SalpiniValentina Svicher
Apr 4, 2020·Medicine·Lan-Ying HeWei-Qing Chen
Jun 3, 2018·Clinical Medicine : Journal of the Royal College of Physicians of London·Apostolos KoffasPatrick Tf Kennedy
Aug 3, 2021·Frontiers in Medicine·Wei-Chih SunWei-Lun Tsai